New hope for tough bladder cancers: experimental combo therapy shows promise
NCT ID NCT03022825
Summary
This study is testing a new combination treatment for people with high-grade bladder cancer that has not responded to the standard BCG therapy. The treatment involves placing a liquid containing BCG and/or a drug called N-803 directly into the bladder through a catheter. The goal is to see if this approach can eliminate or control the cancer and prevent it from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accument Rx
Albuquerque, New Mexico, 87109, United States
-
Adult & Pediatric Urology
Omaha, Nebraska, 68114, United States
-
Alaska Clinical Research Center
Anchorage, Alaska, 99503, United States
-
Arkansas Urology
Little Rock, Arkansas, 72211, United States
-
Associated Urologists of North Carolina
Raleigh, North Carolina, 27612, United States
-
Clinical Research Center of Florida
Pompano Beach, Florida, 33060, United States
-
Dwight D. Eisenhower Army Medical Center
Augusta, Georgia, 30905, United States
-
Hoag Memorial Hospital
Newport Beach, California, 92663, United States
-
Integrated Medical Professionals
New York, New York, 10016, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Madigan Army Medical Center
Tacoma, Washington, 98431, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Premier Medical Group of the Hudson Valley
Poughkeepsie, New York, 12601, United States
-
Roswell Park Cancer Insitute
Buffalo, New York, 14263, United States
-
Skyline Urology
Sherman Oaks, California, 91411, United States
-
Skyline Urology
Torrance, California, 90505, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
UCLA Department of Urology
Los Angeles, California, 90024, United States
-
UNC Chapel Hill
Chapel Hill, North Carolina, 27599, United States
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
University of Hawaii Cancer Center
Honolulu, Hawaii, 96814, United States
-
University of Miami Miller School of Medicine-Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Rochester
Rochester, New York, 14642, United States
-
Urology Associates, PC
Englewood, Colorado, 80113, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Virginia Urology
Richmond, Virginia, 23235, United States
-
Winthrop University Hospital Department of Urology
Garden City, New York, 11530, United States
Conditions
Explore the condition pages connected to this study.